CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Novartis Gene Therapies, Inc. et al. vs. Genzyme Corporation et al.

Explore the PTAB proceeding IPR2023-00609 filed by Novartis Gene Therapies, Inc. et al. on 2023-02-22. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Proceeding Overview

Proceeding Number

IPR2023-00609

Filing Date

2023-02-22

Accorded Filing Date

2023-02-22

Institution Decision Date

2023-08-30

Last Modified Date

โ€”

Proceeding Type

IPR

Termination Date

2023-08-30

Trial Status

Institution Denied

Parties & Counsel

Patent Owner / Respondent

Patent Information

1 Patent Involved
Respondent Application Number 12661553
Respondent Patent Number 9051542
Legal Expiration Date
2030-03-19 Active (3.3 yrs remaining)
Injunction Viability (35 U.S.C. ยง 283) Active Threat
Respondent Inventor John Fraser Wright et al
Respondent Tech Center TC 1600 - Biotechnology & Organic Chemistry

Tribunal & APJ Panel Intelligence

Board Intelligence

Tribunal

Patent Trial and Appeal Board (USPTO)

Technology Center

TC 1600 - Biotechnology & Organic Chemistry

Decisions Rendered

1 Total

Proceeding Status

Institution Denied

Board Decisions & Rulings (1)

Institution Denied 2023-08-30
Institution Decision: Deny
37 CFR 42.107, 35 USC 314, 37 CFR 42.100, 35 USC 311

Address and Attorney/Agent Information

40 Registered Practitioners

Power of Attorney & Correspondence

Firm / Entity Name LISA P. RASMUSSEN - SANOFI
Customer Number 5487
Address 450 WATER STREET, Cambridge, MA, 02141, UNITED STATES

Attorney / Agent Information

Reg # Name Phone
36844 Joseph Kirk Jr +1 908-981-6911
39150 John Conway +1 908-981-6688
40564 Anne Collins +1 978-341-0036
44045 Sandra Brockman-Lee +1 857-523-9199
45736 Pamela Torpey +1 508--27-1-0683
45979 Milan Vinnola +1 619-238-0062
47150 Nicole Parsons +1 617-685-5697
52610 Kelly Bender +1 248-593-0581

Global Patent Family Cross-Litigation Radar

CasLoc 360ยฐ Radar 6 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

๐Ÿ‡บ๐Ÿ‡ธ
U.S. District Courts Counterparts in force
๐Ÿ›๏ธ
USPTO PTAB Trials 3 proceedings
๐Ÿ‡ช๐Ÿ‡บ
Unified Patent Court (UPC) Counterparts in force
๐Ÿ‡ฉ๐Ÿ‡ช
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (6): ๐Ÿ‡บ๐Ÿ‡ธ US
Parallel Proceedings Across Jurisdictions (3 found):
PTAB: 3
USPTO PTAB Trial 2025-06-26
IPR2025-01194

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

Asserted Patent
Status: Discretionary Denial
USPTO PTAB Trial 2025-06-26
IPR2025-01195

Sarepta Therapeutics, Inc. et al. v. Genzyme Corporation et al.

U.S. Continuation Sibling (7704721)
Status: Discretionary Denial
USPTO PTAB Trial 2023-02-22
IPR2023-00608

Novartis Gene Therapies, Inc. et al. v. Genzyme Corporation et al.

Asserted Patent
Status: Institution Denied
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Proceeding Documents

68
24

Notice: refund approved NOTICE

2023-10-11 FILING PARTY: BOARD
23

'542 Petitioner's Request for Refund OTHER

2023-10-04 FILING PARTY: PETITIONER
22

Institution Decision: Deny DECISION

2023-08-30 FILING PARTY: BOARD
21

'542 Petitioner's Updated Exhibit List NOTICE

2023-08-23 FILING PARTY: PETITIONER
1028

Novartis Exhibit 1028_263 - Memorandum Opinion Markman Exhibit

2023-08-23 FILING PARTY: PETITIONER

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc